Intercept Pharmaceuticals Price on September 6, 2022

ICPTDelisted Stock  USD 19.00  0.00  0.00%   
If you're considering investing in Intercept Stock, it is important to understand the factors that can impact its price. As of today, the current price of Intercept Pharmaceuticals stands at 19.00, as last reported on the 23rd of April, with the highest price reaching 19.01 and the lowest price hitting 18.98 during the day. We have found twenty-seven technical indicators for Intercept Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please check out Intercept Pharmaceuticals' Downside Deviation of 2.36, risk adjusted performance of 0.0862, and Market Risk Adjusted Performance of 0.5891 to validate if the risk estimate we provide is consistent with the expected return of 0.0%.
  
Intercept Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
ICPT
Based on monthly moving average Intercept Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Intercept Pharmaceuticals by adding Intercept Pharmaceuticals to a well-diversified portfolio.

Intercept Pharmaceuticals Valuation on September 6, 2022

It is possible to determine the worth of Intercept Pharmaceuticals on a given historical date. On September 6, 2022 Intercept was worth 17.69 at the beginning of the trading date compared to the closed value of 16.32. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Intercept Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Intercept Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Intercept Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Intercept Pharmaceuticals' related companies.
 Open High Low Close Volume
  18.05    18.64    17.66    17.82    523,600  
09/06/2022
  17.69    17.69    16.28    16.32    624,600  
  16.25    16.97    16.25    16.81    578,900  
Backtest Intercept Pharmaceuticals  |  Intercept Pharmaceuticals History  |  Intercept Pharmaceuticals Valuation   PreviousNext  
Open Value
17.69
16.32
Closing Value
17.69
Upside

Intercept Pharmaceuticals Trading Date Momentum on September 6, 2022

On September 07 2022 Intercept Pharmaceuticals was traded for  16.81  at the closing time. The top price for the day was 16.97  and the lowest listed price was  16.25 . The trading volume for the day was 578.9 K. The trading history from September 7, 2022 was a factor to the next trading day price appreciation. The trading delta at closing time against the next closing price was 3.00% . The trading delta at closing time against the current closing price is 7.17% .

Intercept Pharmaceuticals Fundamentals Correlations and Trends

By evaluating Intercept Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Intercept Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Intercept financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Intercept Pharmaceuticals Stock history

Intercept Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Intercept is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Intercept Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Intercept Pharmaceuticals stock prices may prove useful in developing a viable investing in Intercept Pharmaceuticals
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company was incorporated in 2002 and is headquartered in New York, New York. Intercept Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 437 people.

Intercept Pharmaceuticals Stock Technical Analysis

Intercept Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of Intercept Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Intercept Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Intercept Pharmaceuticals Period Price Range

Low
September 6, 2022
-1.37  -7.74%
High

 17.69 

     

 16.32 

Intercept Pharmaceuticals April 23, 2024 Market Strength

Market strength indicators help investors to evaluate how Intercept Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Intercept Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Intercept Pharmaceuticals stock market strength indicators, traders can identify Intercept Pharmaceuticals entry and exit signals to maximize returns

Intercept Pharmaceuticals Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Intercept Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Intercept Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Intercept to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey.
You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Other Consideration for investing in Intercept Stock

If you are still planning to invest in Intercept Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Intercept Pharmaceuticals' history and understand the potential risks before investing.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
CEOs Directory
Screen CEOs from public companies around the world
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios